# DAPZURA RT

NDC: 60977-145
Generic name: daptomycin
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220125

FDA application: NDA213645

## Active ingredients

- DAPTOMYCIN: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60977-145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60977-145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb1283e1-35b8-425c-b338-d9ac0c7161f8